Biotech Investor RA Capital Makes Strong Case for New SPAC (The Deal)
Biotech investor RA Capital Management LLP has registered a special purpose acquisition vehicle, Therapeutics Acquisition Corp., to raise $115 million. The SPAC is represented by Technology lawyer Jocelyn Arel of Goodwin. Read The Deal article here.